期刊文献+

MCF-7荷瘤裸鼠不同树突状细胞亚群凋亡的研究 被引量:1

Apoptosis of dendritic cell subsets in MCF-7 tumor-bearing nude mice
原文传递
导出
摘要 目的:通过建立MCF-7荷瘤裸鼠模型,研究树突状细胞(DCs)不同亚群的凋亡,为设计新的免疫治疗方法和新的疫苗提供详尽信息。方法:建立MCF-7裸鼠模型,随机分为荷瘤组和对照组,肿块达5 mm后处死裸鼠,取骨髓单个核细胞进行DCs诱导、分化,流式细胞仪上检测表面分子标志CD86、CD83、MHC-Ⅱ及CD34,AnnexinⅤ检测CD11c及CD123了解DCs亚群的凋亡率。结果:骨髓起源单个核细胞培养至第9天出现典型DCs形态特征,荷瘤组和对照组细胞均高表达CD86、CD83及MHC-Ⅱ,而CD34表达两组均较低。荷瘤组CD11c+CD123-细胞为(52.01±1.43)%,对照组为(56.36±1.76)%;CD123+CD11c-细胞荷瘤组为(32.19±1.71)%,对照组为(28.95±1.39)%。荷瘤组mDC凋亡率为(23.64±2.43)%,较对照组(20.05±2.49)%高,P<0.05。荷瘤组小鼠pDC凋亡率为(11.53±2.92)%,较对照组(14.96±2.96)%低,P<0.05。结论:MCF-7乳腺癌小鼠体内DCs存在mDC和pDC两种亚型,mDC凋亡率增加,使诱导Th1免疫反应能力减低;而pDC凋亡率减少,诱导体内免疫耐受的发生,机体抗肿瘤免疫反应能力因而下降。 OBJECTIVE:Establishing MCF-7 tumor-bearing mice and studying the apoptosis of DCs subsets,in order to give the particular information to design the new immune-therapeutic method and new vaccines in breast cancer. METH- ODS: MCF-7 cell line was implanted subcutaneously in BALB/C nude mice to develop implant-tumor. Then the nude mice were randomly allocated into two groups. Mice were sacrificed when tumor size reached 5mm in diameter. Bone marrow- derived mononuclear cells were induced and differentiated. DCs were identified by flow cytometry. The apoptosis of DC subsets were verified by Annexin V using flow cytometry. RESULTS: The obvious morphologic characteristics of DCs were observed when the bone marrow-derived monoelear cell had been cultured for 9days. High level expressions of CD86, CD83 and MHC-I] were similarly observed in two groups, while the expression of CD34 was very low. The cells of CD11 c+ CD123- in tumor-bearing mice was (52.01±1.43)% and that of control mice was (56.36 ±1.76)%. The cells of CDllc CD123+ in tumor-bearing mice was (32.19±1.71)% ,while that of control mice was (28.95±1.39)%. The pro- portion of apoptotic mDCs in tumor-bearing mice was significantly increased [ (23.64± 2.43)%, vs (20.05 ± 2.49) %, P〈0.05]. In contrast, in tumor-bearing mice, the percentage of apoptotic pDC was lower than that in control mice [ (11.53 ± 2.92) 0% vs ( 14.96±2.96)%, P 〈 0.05 ]. CONCLUSIONS: MDC and pDC are two mDC subsets of MCF-7 breast cancer mice. The rate of apoptotic mDCs in tumor-bearing mice is higher significantly than that in control mice. It suggests that mDC in MCF-7 breast cancer mice induced a weak Thl response. The rate of apoptotie pDCs in tumor-bear- ing mice is lower significantly than that in control mice. It suggested that pDC induced immune tolerance, which resulted indecreasing the antitumor immune responses in vivo.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2013年第3期172-176,共5页 Chinese Journal of Cancer Prevention and Treatment
基金 广东省科技厅立项项目(2007B031515016)
关键词 乳腺肿瘤 树突细胞 亚群 细胞凋亡 流式细胞术 裸鼠 breast neoplasms dendritic ceils subsets apoptosis flow cytometry nude mice
  • 相关文献

参考文献15

  • 1Forouzanfar MH, Foreman K J, Delossantos AM, et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a sys- tematic analysis t[J]. Lance,2011,378(9801) : 1461-1484.
  • 2马骏,傅继华.生活方式与乳腺癌发病相关性的研究进展[J].中华肿瘤防治杂志,2012,19(5):397-400. 被引量:26
  • 3Murdoch C, Muthana M, Coffelt SB, et al. The role of myeloid ceils in the promotion of tumour angiogenesis[J]. Nat Rev Canc- er,2008,8(8) :618-631.
  • 4Huarte E, Cubillos-Ruiz JR, Nesbeth YC, et al. Depletion of den- dritic cells delays ovarian cancer progression by boosting antitu- mot immunity[J]. Cancer Res, 2008,68(18) : 7684-7691.
  • 5罗建飞,陈必成,陈忠华.小鼠骨髓来源树突状细胞的分离与扩增培养[J].微循环学杂志,2005,15(1):29-31. 被引量:7
  • 6Jego G, Palucka AK, Blanck JP, et al. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6[J]. Immunity, 2003,19 (2) : 225-234.
  • 7Ueno H, Klechevsky E, Morita R, et al. Dendritic cell subsets in health and disease[J], lmmunol Rev, 2007,219 (10) : 118-142.
  • 8徐永茂,徐冬云,张南征,陈复兴,张国龙,刘军权,李春艳.NP方案化疗同步放疗并序贯过继免疫细胞治疗非小细胞肺癌的临床研究[J].中华肿瘤防治杂志,2011,18(13):1032-1035. 被引量:18
  • 9Lou Y, Liu C, Kim GJ, et al. Plasmacytoid dendritic cells syner- gize with myeloid dendritic cells in the induction of antigen-spe- cific antitumor immune responses[J]. Immunol, 2007, 178(3) : 1534-1541.
  • 10O' Neill DW, Adams S, Bhardwaj N. Manipulating dendritic cell biology for the active immunotherapy of cancer[J]. Blood, 2004, 104(8) :2235-2246.

二级参考文献40

  • 1周清华.局部晚期非小细胞肺癌治疗的争议与共识[J].医师进修杂志(外科版),2004,27(10):10-14. 被引量:6
  • 2Steinman RM,Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. Ⅰ.morphology ,quantitation ,tissuer distribution. J Exp Med,1973,137(5):1 142~1 162.
  • 3Labeur MS,Roters B ,Pers B, et al. Generation of tumor immunity by bone marrow derive dendritic cells correlates with dendritic cell maturation stage. J Immunol ,1999,162(1):168~175 .
  • 4Morse MA ,Zhou LJ ,Tedder TF, et al. Generation of dendritic cells in vitro from peripheral blood mono nuclear Cells with granulocyte macrophage colony stimulating factor, interleukin 4,and tumor necrosis factor alpha for use in cancer immune therapy. Ann Surg,1997,226(1):6~16.
  • 5Yang S,Darrow TL ,Vervaert CE,et al. Immune therapeutic potential of tumor antigen pulsed and unpulsed dendritic cells generated from murine bone marrow.Cell Immnol ,1997,179(1):84~95.
  • 6Moser M, Murphy KM. Dendritic cell regulation of TH1-TH2 development .Nature Immunology 2000,1(3):199~205.
  • 7Babik JM,Adams E, Tone Y, et al.Expression of murine IL-12 is regulated by translational control of the P35 subunit.J Immunol,1999,162(10):4 067~4 078.
  • 8Stuckey A. Breast cancer: Epidemiology and risk factors[J]. Clin Obstet Gyneeol, 2011, 54(1) :96-102.
  • 9Manuti SS, Ulrich CM, White E. Folate and one-carbonme tabolism nuteients from supplements and diet in relation to breast cancer risk[J]. Am J Clin Nutr, 2009, 89(2):624-633.
  • 10Gibson LJ, Hery C Mitton N, et al. Risk factors for breast cancer among Filipino women in Manila[J]. Int J Cancer, 2010, 126(2) :515-521.

共引文献48

同被引文献14

  • 1Matsuda A,Katanoda K. Five-year relative survival rate of lung cancer in the USA, Europe and Japan[J]. Jpn J Clin Oncol, 2013,43 (12) : 1287-1288.
  • 2Marongiu L,Donini M,Toffali L, et al. ESAT-6 and HspX im- prove the effectiveness of BCG to induce human dendritic ceils- dependent Thl and NK cells activation[J]. PLoS One, 2013, 8(10) :756-784.
  • 3Zhu Y,Zhang H,Li Y,et al. Efficacy of postoperative adjuvant transfusion of cytokine-induced killer cells combined with chemo- therapy in patients with colorectal cancer[J]. Cancer Immunol Immunother, 2013,62 (10) :1629-1635.
  • 4Yuanying Y, Lizhi N, Feng M, et al. Therapeutic outcomes of combi- ning cryotherapy, chemotherapy and DC-CIK immunotherapy in the treatment of metastatic non-small cell lung cancer[J]. Cryobiology, 2013,67(2) :235-240.
  • 5Sandler A,Hirsh V,Reck M,et al. An evidence-based review of the incidence of CNS bleeding with anti-VEGF therapy in non- small cell lung cancerpatients with brain metastases[J]. Lung Cancer, 2012,78(1) : 1-7.
  • 6Park SY,Jung CH, Song B, et al. Pro-apoptotic and migration- suppressing potential of EGCG, and the involvement of AMPK in the p53-mediated modulation of VEGF and MMP-9 expression [J]. Oncol Lett,2013,6(5) : 1346-1350.
  • 7Darakhshan S, Bidmeshkipour A, Khazaei M, et al. Synergistic effects of tamoxifen and tranilast on VEGF and romp-9 regulation in cul- tured human breast cancer cells[J]. Asian Pac J Cancer Prey,2013, 14(11) :6869-6874.
  • 8Kumar P, Chatterjee S, Aeharya S, et al. Significant modulation of macrophages associated cytokines TNF-a, VEGF and apopto- toic protein Bax, Bcl2 abrogates tumor cells[J]. Cell Immunol, 2013,284 (2) : 172-181.
  • 9徐永茂,徐冬云,张南征,陈复兴,张国龙,刘军权,李春艳.NP方案化疗同步放疗并序贯过继免疫细胞治疗非小细胞肺癌的临床研究[J].中华肿瘤防治杂志,2011,18(13):1032-1035. 被引量:18
  • 10张俊萍,毛光华,史天良,杨晓玲,肖艳,张丽彬,冯慧晶,韩亚萍,智婷,王江涛,贾林梓.DC-CIK联合化疗治疗晚期非小细胞肺癌的临床疗效[J].中国肿瘤生物治疗杂志,2011,18(4):424-429. 被引量:71

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部